Topvision Eye Specialist BhdXKLS:0332 +3.03%53 ROE % is 0.77% as of Mar. 2026, which is 93% below its 10-year median of 11.62. GuruFocus rates XKLS:0332 with a GF Score™ of 53/100 and a GF Value™ of RM0.68 (Significantly Undervalued). The stock has 8 warning signs investors should review. Among 623 Healthcare Providers & Services companies, Topvision Eye Specialist Bhd ranks worse than 59.87% on this metric.
The historical rank and industry rank for Topvision Eye Specialist Bhd's ROE % or its related term are showing as below:
XKLS:0332'
s ROE % Range Over the Past 10 Years
Min: 2.7 Med: 11.62 Max: 25.67
Current: 2.77
During the past 11 years, Topvision Eye Specialist Bhd's highest ROE % was 25.67%. The lowest was 2.70%. And the median was 11.62%.
XKLS:0332's ROE % is ranked worse than 59.87% of 623
companies
in the Healthcare Providers & Services industry
Industry Median: 5.86
vs XKLS:0332: 2.77
Topvision Eye Specialist Bhd (XKLS:0332) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Topvision Eye Specialist Bhd ROE % Related Terms
Topvision Eye Specialist Bhd ROE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Topvision Eye Specialist Bhd's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Topvision Eye Specialist Bhd ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Topvision Eye Specialist Bhd's ROE % distribution charts can be found below:
* The bar in red indicates where Topvision Eye Specialist Bhd's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Topvision Eye Specialist Bhd (XKLS:0332) has a ROE % of 0.77% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Topvision Eye Specialist Bhd and its competitors. This is 93% below median its historical median of 11.62. Over the past decade, Topvision Eye Specialist Bhd's ROE % has ranged from 2.70 to 25.67. According to the industry distribution chart, Topvision Eye Specialist Bhd ranks #373 out of 623 companies in the Healthcare Providers & Services industry, placing it in the top 59.9%.
Is Topvision Eye Specialist Bhd's ROE % too high?
Topvision Eye Specialist Bhd's current ROE % of 0.77% is 93% below median its 10-year median of 11.62. Over the past 10 years, this metric has ranged from a low of 2.70 to a high of 25.67. The Healthcare Providers & Services industry median ROE % is 5.86. Topvision Eye Specialist Bhd's value of 0.77% is 86.9% below this industry median. Based on the distribution chart, Topvision Eye Specialist Bhd ranks #373 out of 623 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Topvision Eye Specialist Bhd has a GF Score™ of 53/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Topvision Eye Specialist Bhd's ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Topvision Eye Specialist Bhd ranks #373 out of 623 companies for ROE %. This places Topvision Eye Specialist Bhd in the lower half of its industry. The industry median ROE % is 5.86. Topvision Eye Specialist Bhd's value of 0.77% is 86.9% below this benchmark. Historically, Topvision Eye Specialist Bhd's own ROE % has ranged from 2.70 to 25.67 over the past decade. While the company's 10-year median is 11.62 vs. the industry median of 5.86, Topvision Eye Specialist Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.86, based on 623 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Topvision Eye Specialist Bhd's current ROE % of 0.77% is 86.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Topvision Eye Specialist Bhd and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Topvision Eye Specialist Bhd's current ROE % is 0.77%, which is 93% below median its own 10-year median of 11.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Topvision Eye Specialist Bhd stock overvalued right now?
Based on GuruFocus' analysis, Topvision Eye Specialist Bhd (XKLS:0332) is currently considered Significantly Undervalued. The stock's GF Value™ is RM0.68, compared to a current price of RM0.17 — trading 75% below its estimated fair value. The current ROE % is 0.77%, which is 93% below median its 10-year median of 11.62 and 86.9% below the Healthcare Providers & Services industry median of 5.86. Topvision Eye Specialist Bhd's overall GF Score™ is 53/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Topvision Eye Specialist Bhd (XKLS:0332), the current ROE % is 0.77% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Topvision Eye Specialist Bhd (XKLS:0332) Overvalued in 2026?
Based on GuruFocus' analysis, Topvision Eye Specialist Bhd stock appears to be undervalued.
The current stock price of RM0.17 is trading 75% below its estimated GF Value™ of RM0.68.
GuruFocus considers Topvision Eye Specialist Bhd to be Significantly Undervalued.
Key valuation signals for XKLS:0332:
ROE %: 0.77% (93% below median its 10-year median of 11.62)
GF Value™: RM0.68 vs. price of RM0.17 (75% below fair value)
Industry Position: 86.9% below the Healthcare Providers & Services median (#373 of 623)
No single metric tells the full story. See the XKLS:0332 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Topvision Eye Specialist Bhd is principally involved in the provision of ophthalmology services and related medical consultancy services. The company is also engaged in the marketing of eye supplements and health food products. The company derives a majority of its revenue from its ophthalmology services business, providing treatments for general as well as complex eye diseases. Geographically, it operates in Malaysia.
53GF Score
Get the complete analysis for XKLS:0332
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0332 has been successfully added to your 
